A detailed history of Pacer Advisors, Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, Pacer Advisors, Inc. holds 8,032 shares of LIVN stock, worth $424,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,032
Previous 8,102 0.86%
Holding current value
$424,812
Previous $419,000 7.16%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$48.6 - $57.12 $3,402 - $3,998
-70 Reduced 0.86%
8,032 $449,000
Q4 2023

Jan 16, 2024

BUY
$43.45 - $53.66 $157,332 - $194,302
3,621 Added 80.81%
8,102 $419,000
Q3 2023

Nov 13, 2023

SELL
$50.12 - $58.87 $340,816 - $400,316
-6,800 Reduced 60.28%
4,481 $236,000
Q2 2023

Jul 12, 2023

BUY
$42.28 - $51.43 $476,960 - $580,181
11,281 New
11,281 $580,000
Q4 2022

Feb 06, 2023

BUY
$43.88 - $56.16 $349,504 - $447,314
7,965 Added 347.06%
10,260 $569,000
Q3 2022

Oct 18, 2022

BUY
$48.37 - $66.5 $111,009 - $152,617
2,295 New
2,295 $117,000
Q1 2022

Apr 05, 2022

SELL
$71.02 - $86.99 $554,879 - $679,652
-7,813 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$76.72 - $92.68 $16,571 - $20,018
216 Added 2.84%
7,813 $683,000
Q3 2021

Oct 15, 2021

BUY
$76.02 - $88.62 $20,069 - $23,395
264 Added 3.6%
7,597 $602,000
Q2 2021

Jul 21, 2021

BUY
$73.44 - $87.01 $157,381 - $186,462
2,143 Added 41.29%
7,333 $617,000
Q1 2021

Apr 05, 2021

SELL
$62.9 - $82.41 $15,096 - $19,778
-240 Reduced 4.42%
5,190 $383,000
Q4 2020

Jan 20, 2021

BUY
$46.01 - $68.74 $249,834 - $373,258
5,430 New
5,430 $360,000
Q3 2018

Nov 14, 2018

SELL
$101.02 - $130.95 $1.39 Million - $1.81 Million
-13,792 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $1.13 Million - $1.45 Million
13,792 New
13,792 $1.38 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.83B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.